NASDAQ:IPSC

Century Therapeutics Stock News

Healthcare > Biotechnology

Buy IPSC

*Your capital is at risk

$2.07

-0.100 (-4.61%)

At Close: Jun 03, 2026

Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

04:01pm, Tuesday, 22'nd Jun 2021

PHILADELPHIA, June 22, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immu

Century Therapeutics Announces Pricing of Initial Public Offering

06:15pm, Thursday, 17'th Jun 2021

PHILADELPHIA, June 17, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, tod

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by